Hypoadrenocorticism after Trilostane (Vetoryl) in dogs

The FDA has received 689 reports of hypoadrenocorticism in dogs after Trilostane. That is 5.8% of all reports for this medicine, compared with 0.1% across reports for all dog medicines, so it is reported unusually often with this medicine.

689Reports
53%Marked serious
9.1%Recovered
7.7%Died or euthanised
84 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
15 3.1%
1–2 days
13 2.7%
3–7 days
22 4.6%
1–4 weeks
101 21%
Over a month
332 69%

How the animals did

Recovered
61 8.9%
Recovered with lasting effects
2 0.3%
Still unwell when reported
115 17%
Died
13 1.9%
Euthanised
40 5.8%
Not known
458 66%

Problems reported at the same time

Age of the animals

Under 1 year
0
1–3 years
0
4–7 years
46
8–11 years
330
12+ years
294

About this medicine

Trilostane treats Cushing's disease (an overactive adrenal gland).

Products with this ingredient include Vetoryl. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Trilostane cause hypoadrenocorticism in dogs?
689 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 84 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hypoadrenocorticism with similar medicines

All reported side effects of Trilostane in dogs · Medicines most reported with hypoadrenocorticism